Trichotillomania Clinical Trials 2023

What are the top hospitals conducting trichotillomania research?

Trichotillomania, a unique and often misunderstood condition characterized by the irresistible urge to pull out one's hair, has garnered attention from top hospitals across the United States. In Chicago, the University of Chicago leads the way with one active clinical trial dedicated to trichotillomania and an impressive history of seven previous trials. Their pioneering efforts in this field began in 2008, showcasing their commitment to understanding and treating this complex disorder. Similarly, at Yale Child Study Center in New Haven, researchers are currently conducting one active trial for trichotillomania after their initial investigation commenced in 2009.

Notably joining these institutions is Johns Hopkins University School of Medicine in Baltimore that recently initiated its own research project on trichotillomania earlier this year where only a single ongoing clinical experiment takes place; Utah State University situated in Logan stands alongside them as they both too have conducted solitary trials yet contributing significantly towards scientific exploration through their respective projects which embarked upon respectively during2018.Ultimately rounding off this list is Massachusetts General Hospital’s Cognitive-Behavioral Therapy and Behavioral Medicine Programs located strategically within Boston.This establishment deploys its resources into investigating manifestations of trichotillomania through behavioral medicine programs wherein similar again with other institutes there exists an equally single current research endeavor while sharing common grounds having achieved similar numbers for past experiments initially starting since 2010

These distinguished hospitals' dedication to advancing knowledge about trichotillomania not only offers hope but also fosters breakthroughs that can potentially improve the lives of individuals affected by this condition. By shedding light on this perplexing disorder through careful study and innovative approaches, these medical institutions bring us closer to effective treatments and compassionate care for those grappling with trichotillomania nationwide

Which are the best cities for trichotillomania clinical trials?

When it comes to trichotillomania clinical trials, several cities offer opportunities for individuals seeking innovative treatments. Chicago, Illinois; New Haven, Connecticut; Baltimore, Maryland; Logan, Utah; and Boston Massachusetts each have one active trial exploring different interventions such as Aripiprazole, Valbenazine Oral Capsule, HabitAware Keen2 device, Treatment options, and Cognitive Behavioral Therapy (CBT). These locations provide potential participants with access to cutting-edge research that may lead to improved management of trichotillomania symptoms.

Which are the top treatments for trichotillomania being explored in clinical trials?

Clinical trials are paving the way for innovative treatments to address trichotillomania. Among the top contenders is aripiprazole, which has shown promise in one active trial and holds its ground with one all-time trichotillomania trial since its introduction in 2023. Another contender making waves is valbenazine oral capsule, also involved in one active trial and showing potential through one all-time trichotillomania trial starting from 2023. Additionally, HabitAware Keen2 offers hope with ongoing exploration through one active trial after being listed as a treatment option in 2021. Finally, cognitive-behavioral therapy (CBT) continues to demonstrate effectiveness as a non-pharmaceutical approach that has been under investigation since 2010, boasting participation in both an active and an all-time trichotillomania trial. These advancements signify progress towards improved care for individuals battling this challenging condition.

What are the most recent clinical trials for trichotillomania?

Exciting advancements are underway in the field of trichotillomania research, with recent clinical trials shedding light on potential treatment options. One notable trial examined the use of valbenazine oral capsules for managing trichotillomania symptoms. As a Phase 2 study, it offers valuable insights into the efficacy and safety of this medication in addressing hair-pulling disorder. By focusing on these innovative approaches, researchers aim to improve the lives of individuals affected by trichotillomania and provide them with new avenues for therapeutic intervention.

What trichotillomania clinical trials were recently completed?

In June 2021, the University of Chicago successfully completed a clinical trial investigating the potential efficacy of Memantine in treating trichotillomania. This recent milestone highlights the ongoing efforts to find effective treatments for this challenging disorder and offers hope for individuals struggling with compulsive hair-pulling behaviors.